Search

everythinglearnresearchcommunity

for

Search:↓

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

The main cause of excessive hair growth in Turkish women is Polycystic ovary syndrome, but in about one fifth of cases, the reason for high male hormone levels is unknown.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Raising awareness about PCOS can improve women's quality of life.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

PCOS is caused by both genetics and environmental factors like diet and obesity.